This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2023 Jan 5;388(1):55-69.

doi: 10.1056/NEJMra2211764.

New Approaches to Chronic Hepatitis B

Geoffrey Dusheiko¹, Kosh Agarwal¹, Mala K Maini¹

Affiliations

Affiliation

¹ From University College London (G.D.), Kings College Hospital London (G.D., K.A.), Kings College London (K.A.), and the Institute of Immunity and Transplantation, University College London (M.K.M.) - all in London.

PMID: 36599063
DOI: 10.1056/NEJMra2211764

Review

New Approaches to Chronic Hepatitis B

Geoffrey Dusheiko et al. N Engl J Med. 2023.

. 2023 Jan 5;388(1):55-69.

doi: 10.1056/NEJMra2211764.

Authors

Geoffrey Dusheiko¹, Kosh Agarwal¹, Mala K Maini¹

Affiliation

¹ From University College London (G.D.), Kings College Hospital London (G.D., K.A.), Kings College London (K.A.), and the Institute of Immunity and Transplantation, University College London (M.K.M.) - all in London.

PMID: 36599063
DOI: 10.1056/NEJMra2211764

No abstract available

PubMed Disclaimer

Comment in

New Approaches to Chronic Hepatitis B.
Tseng TC, Kao JH. Tseng TC, et al. N Engl J Med. 2023 Mar 23;388(12):1148. doi: 10.1056/NEJMc2301248. N Engl J Med. 2023. PMID: 36947479 No abstract available.
New Approaches to Chronic Hepatitis B. Reply.
Dusheiko G, Agarwal K, Maini MK. Dusheiko G, et al. N Engl J Med. 2023 Mar 23;388(12):1148-1149. doi: 10.1056/NEJMc2301248. N Engl J Med. 2023. PMID: 36947480 No abstract available.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.